MAAT INDEX

CLAIM #22707 · EMR (EMR) · 2024Q2 earnings call · May 8, 2024 · due Sep 30, 2024

exiting the year in that mid-single digit, low single-digit type of range on orders is very, very feasible.

Lal Karsanbhai · CEO

PENDING
graded after results covering Sep 30, 2024 are reported

In context

year is up double digit, 10%, on orders. Certainly -- and the 3 months has turned positive as well. So we flipped that to the low single digits on a 3-month basis, trailing 3-month basis. So feel good about the start, feel good about the funnel and the conversion and the markets. And it's again driven by the process and hybrid environment across most of the world areas. Discrete, we're watching very carefully. As we said, we expect that to turn now a quarter later than originally expected. But we're seeing green shoots that started developing in March and into April, particularly in Western Europe, in Germany around machine makers and some of the discrete industries. So optimistic start for the quarter, again gave us the confidence as we tested our businesses and worked out process that exiting the year in that mid-single digit, low single-digit type of range on orders is very, very feasible. Andrew Kaplowitz: Lal, just a quick follow-up to that last comment. Did you just get a couple of larger projects in April? Is that kind of what happened to swing that? Surendralal Karsanbhai: No, no, no. There's funnel conversion, Andy, but nothing exemplary there. Andrew Kaplowitz: Okay. And then maybe what are your customers telling you on the NATI side as to sort of why the recovery is still delayed there? And if NATI is still slower to turn than you currently expect, do you still have more flexibility to sort of continue to push the envelope on integration cost-out? And then ultimately, I know Ram said you're still targeting the $185 million. But could you do more than that? Surendralal Karsanbhai: No, certainly. Look, I think the team has a great set of ideas on their walls in te

Verify independently

SEC filings for EMR · Claim quote is verbatim from the 2024Q2 earnings call.